The Therapeutic Goods Administration (TGA), has set its largest month on record for Medicinal cannabis approvals.

The TGA has published its February figures for SAS category B approvals setting another milestone with 8057 patients approved for medicinal cannabis. This is yet another strong month showing continuous demand for medicinal cannabis products. As of the 28th of February 2020, the TGA has approved nearly 100,000 SAS category B Applications for unapproved medical cannabis products (TGA: SAS Category B approval statistics).

Please note: these numbers do not include patients accessing medicinal cannabis via clinical trials or via Authorised Prescribers (medical practitioners who are approved to prescribe medical cannabis without needing to wait for patient approval from the TGA). There are now 215 Authorised Prescribers in Australia (TGA: SAS Category B approval statistics).

Would you like information on how to access medicinal cannabis?

Please download our Simple steps to access for more information or contact our team on (08) 6280 0050. or info@littlegreenpharma.com.au.

Little Green Pharma is also sponsoring a medicinal cannabis study looking at the impact of quality of life across a range of chronic health conditions. If you want to learn more about this study and how to access discounted medication please visit: theQuestinitiative

Little Green Pharma's profile picture

By Little Green Pharma

Return to Top